[Translation] A multicenter, randomized, double-blind, placebo-controlled, group-sequential phase III clinical trial on the efficacy and safety of KGF-2 in the treatment of superficial second-degree burn wounds
1. 进一步评价冻干重组人角质细胞生长因子-2外用治疗皮肤局部浅Ⅱ度灼伤创面的安全耐受性;
2. 扩大样本量评价冻干重组人角质细胞生长因子-2治疗皮肤局部浅Ⅱ度灼伤创面的临床有效性,为临床应用提供科学试验依据。
[Translation] 1. Further evaluate the safety and tolerability of freeze-dried recombinant human keratinocyte growth factor-2 for topical treatment of superficial second-degree burns on the skin;
2. Expand the sample size to evaluate the clinical effectiveness of freeze-dried recombinant human keratinocyte growth factor-2 for the treatment of superficial second-degree burns on the skin, and provide scientific experimental basis for clinical application.